-
Table of Contents
The Role of HPMC K40M in Gastroretentive Dosage Forms
Gastroretentive dosage forms are designed to remain in the stomach for an extended period of time, allowing for controlled release of the drug and improved bioavailability. Hydroxypropyl methylcellulose (HPMC) is a commonly used polymer in the development of such dosage forms, with HPMC K40M being particularly effective due to its unique properties.
What is HPMC K40M?
HPMC K40M is a cellulose ether that is widely used in pharmaceutical formulations as a thickening agent, stabilizer, and film former. It is a hydrophilic polymer that swells in water to form a gel, making it ideal for use in controlled-release dosage forms.
Benefits of HPMC K40M in Gastroretentive Dosage Forms
- Enhanced drug solubility and dissolution rate
- Prolonged gastric residence time
- Improved drug release profile
- Reduced variability in drug absorption
Case Studies
Several studies have demonstrated the effectiveness of HPMC K40M in the development of gastroretentive dosage forms. For example, a study published in the International Journal of Pharmaceutics found that HPMC K40M-based floating tablets of metformin hydrochloride exhibited prolonged gastric residence time and improved drug release profile compared to conventional tablets.
Statistics
According to a report by Grand View Research, the global gastroretentive drug delivery systems market is expected to reach USD 5.7 billion by 2025, with a compound annual growth rate of 6.5%. This growth is driven by the increasing prevalence of gastrointestinal disorders and the demand for novel drug delivery technologies.
Conclusion
HPMC K40M plays a crucial role in the development of gastroretentive dosage forms, offering numerous benefits such as enhanced drug solubility, prolonged gastric residence time, and improved drug release profile. As the demand for controlled-release formulations continues to grow, HPMC K40M is likely to remain a key ingredient in the formulation of innovative drug delivery systems.